The tumor-rejection antigens of the 1591 ultraviolet fibrosarcoma. Potential origin and evolutionary implications by unknown
THE TUMORREJECTION ANTIGENS OF THE
1591 ULTRAVIOLET FIBROSARCOMA
Potential Origin and Evolutionary Implications
BY RICHARD LINSK, SUZANNE WATTS, ANN FISCHER,
AND ROBERT S . GOODENOW
From the Department of Genetics, University of California, Berkeley, California 94720
Thenature oftumor-specific transplantation antigens has been an object of interest
ever since the initial demonstrations that primary tumorhostscanmake an immune
response capable ofproviding protection against the growth of the tumor (1-4). The
analysis of these products has provided significant insight into tumor biology and
hasled to the development of potential immunological approaches to the treatment
of cancer.
Tumor-specific antigens are often found to be associated with tumors inducedwith
carcinogenic agents such asUVlight or 5-methylcholanthrene (4-6). Initially these
tumor antigens were examined using in vivo tumor rejection assays . Such studies
suggested that in some cases these antigens were immunologically unique . For ex-
ample, analysis ofa panel of highly antigenic UV-induced fibrosarcomas indicated
that immunization with onetumorwould provide little protection against the growth
ofasecond syngeneic tumor (7, 8) . The cumulative analysis ofthese and othertumors
suggested that the repertoire ofpotential antigens might be quite large (9, 10) . The
precise molecularmechanisms bywhich such adiversity of antigens mightbe gener-
ated remained unclear.
To define more precisely the biochemical characteristics and biological functions
oftumor-specific antigens, Schreiber and collaborators undertook the detailed anal-
ysis of the antigenic products ofa single C3H/HeN-derived, UV-induced fibrosar-
coma, 1591 . In the course of these studies, these workers demonstrated that 1591
expresses several genetically distinct tumor antigens responsible for the growth be-
havior of the tumor (11, 12) . In addition, two tumor-reactive mAbs were isolated
which allowed the biochemical analysis ofa subset of these tumor antigens (13) . In-
triguingly, these mAbs appeared to crossreact with various allogeneicMHC haplo-
typesand were able to immunoprecipitatemolecules exhibiting thebiochemical fea-
tures of class IMHC antigens (13, 14) . These data were particularly exciting since
they suggested that the polymorphism observed among tumor antigens might be
analogous to that which has been defined for MHC antigens .
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ORIGIN OF 1591 TUMOR ANTIGENS
Usingthetumor-reactive mAbs in conjunctionwith class I-specific DNA probes,
Stauss et al . (15) isolated from a 1591 genomic library three genes that account for
all of the apparently allogeneic class I reactivities associated with the 1591 tumor.
The sequences of these three genes were determined, and the CTL recognition and
growth behavior of transfectants were examined (16, 17). The conclusion of these
studies was that two of these genes, A149 and A166, were very similar and encoded
products exhibiting significant structural and functional homology with the H-2L'
product, while the third tumor gene, A216, encoded the target antigen of a tumor-
specific CTL clone. None of these genes appeared to exist intact in the C3H ge-
nome, as determined by genomic Southern blot analysis (15). Furthermore all three
genes appeared to be genetically linked, since all genomic polymorphisms were lost
in parallel after selection for the loss of a single antigen. It was postulated that these
novel genes might have been generated by multiple recombination events among
endogenous C3H class I genes (4, 15-17).
In this report, we extend the analysis of these three novel genes and examine fur-
ther thenature ofgenetic polymorphisms in the 1591 tumor. Although an examina-
tion of acomplete set ofC3H H-2- andQa-linked class I sequences failed to identify
a likely progenitor for any of the novel tumor genes, it was discovered that two of
these genes, A149 and A166, are extremely similar to the H-2L and H-2D genes
of the H-2v haplotype. Furthermore, genomic Southern blot analysis suggests that
the homology between the H-2q haplotype and the 1591-associated MHC polymor-
phism extends beyond the A149 and A166 genes. In addition, non-MHC genetic
polymorphism is detected in the 1591 tumor. We believe that these data are most
consistent with an allogeneic origin for the novel MHC antigens expressed by the
1591 tumor.
Materials and Methods
Cell Lines andAnimals.
￿
The following UVinduced tumor cell lines were the kind gift of
Hans Schreiber (Department of Pathology, Unversity of Chicago, Chicago, IL): 1591 and
the CP28- antigen loss variant; uv 802, uv 918, uv 948, uv 4184, puva 2210, puva 3312a.
L cell transfectants ofH-2Kd, Dd, Ld, A149, A166, A216 were generated previously (15). The
H-2q.`.' LF cell lines were generated from fibroblasts grown out ofmurine lung explants. The
KB29 and LR335 C3H UVinduced tumor lines were the gift of Raymond Daynes (Depart-
ment of Pathology, University of Utah, Salt Lake City, UT). The BL-5 cell line was the gift
ofMiriam Lieberman (Stanford University, Stanford, CA). The Swiss 3T3 line was obtained
from American Type Culture Collection (Rockville, MD). C3H/HeJ, BALB/cJ, SJL/J, RIIIS/J,
and A.SW/J mice were purchased from TheJackson Laboratory (Bar Harbor, ME). B10.AKM
was a generous gift from Chella David (Mayo Clinic, Rochester, MN).
DNA Sequences.
￿
1591 tumor genes were cloned from a genomic library (15). C3H/HeN
H-2 genes (18) and Qa genes (our unpublished data) were isolated from among X and cosmid
genomic libraries. All were sequenced by the dideoxy chain termination method using in-
ternal oligonucleotide primers as previously described (16, 18).
Southern Blots.
￿
Mouse genomic DNA was isolated from liver. Tumor DNAs were isolated
from cells or were a gift from Hans Schreiber. Restriction endonucleases were purchased
from New England Biolabs (Beverly, MA). 10 pg of digested DNA was used per lane. Probes
were labeled by the random oligonucleotide priming method ofFeinberg and Vogelstein (19)
to a specific activity of>108 cpm. Some filters were stripped after hybridization with 0.5 M
NaOH and reprobed.
RadioimmuneAssay.
￿
H-2 expression wasdetermined in a cellular radioimmune assay. Briefly,
2.5 x 106 cells were incubated in duplicate wells in microtiter plates with specific anti H-2LINSK ET AL.
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monoclonal antibodies. The following mAbs wereused in this study: CP28 and CP3F4 (13);
30-5-7, 28-14-8, 34-4-20, and 34-1-2 (20, 21). Afterwashing, cells were incubated with 1211-
labelled Protein A. Unbound Protein A was washed out and the amount of radioactivity
measured.
,6-GlucuronidaseAssay.
￿
Celllysate extractswere assayed forS-glucuronidase activity asde-
scribed (22). Briefly, cellswerelysed, extractswereobtained after centrifugation anddiluted
1/10, four 1-ml samples were heat inactivated at 70°C for 0, 5, 10, and 20 min, respectively,
and activity was measured by fluorimetry.
Results
Sequence Comparisonsbetween 1591 and C3HClassIGenes.
￿
The UVinduced, C3H/
HeN-derivedfibrosarcoma, 1591, appearsto express at least three H-2-like products
not found on normal C3Htissue. Previously, three classIgenesencoding these tumor
products were identified within a collection of class 1-hybridizing clones isolated
from a 1591 genomiclibrary (15). Together, these genes, designated A149, A166, and
A216, direct the expression ofall 1591-associated serological and CTL-defined reac-
tivities after transfection into C3H L cells. In addition, each of these three genes
accounts forapolymorphicclass I restrictionfragment detected bygenomicSouthern
blot analysis of 1591 DNA, suggesting that the sequences encoding the 1591 tumor-
specific class I antigens do not exist intact within the ancestral C3H genome (15).
The mechanisms underlying the presence ofthese three genes in 1591 were notdefined,
although it was suggested that theymightbe derived bymutation orrecombination
from endogenous C3H class I genes.
As a first step towards elucidating the molecular origin of these genes, we deter-
mined theirDNA sequences (16). Each ofthe three tumor genes exhibits strong ho-
mology withpreviously sequenced H-2 genes. In particular, A216is highly homolo-
gous to H-2K' throughout its 3'-coding and untranslated region, while A149 and
A166 are homologous to each other and to both H-2Ld and H-2D6 (16).
Ifthe 1591 class I genes areindeed derived bysomesimple recombinational pathway
from endogenous C3H class I genes, it should be possible to identify potential pa-
rental genes on the basis of sequence homology. Recently, we have completed the
DNA sequence analysisofalloftheH-2 and Qregion-linked genes from C3H/HeN
(Watts, S., unpublished data). In an attempt to identify regions of shared identity
between any ofthese C3H genes and the H-2-like genes from the 1591 tumor, se-
quencesfrom each ofthese geneswere aligned inapairwise manner, andthe number
ofpoint differences was determined (Table I). An average of 73 differences exist be-
tweenthese genesin exons2 and3, out of543 positions compared. The most homol-
ogous pair examined was A149 and Q2k, which differed by a total of 36 bases in
these regions. The longest stretch ofidentityobserved in these comparisons was 129
by between the third exon sequences of A216 and H-2Dk. However, these two se-
quences differ at a total of52 positions over the regions compared. Less diversity
is found within exon four, but here also none of the C3H sequences are identical
to the A149, A166, or A216 sequences. Therefore, unless it is assumed that A149,
A166, or A216 were generated as a patchwork from multiple parental genes, it is
difficult to identify a 5' parent for any ofthe tumor genes from among this set of
sequences. Although it remains possible that A149, A166, and A216 were derived
from Tla region genes, the overall structure and sequence ofthe Tla genesthat have
been analyzed to date tend to be even more distinct from that ofH-2 genes (Table1046
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TABLE I
Nucleotide Differences' among 1591 and C3H/HeN Class I Genes
" Sequences (Watts, S., unpublished data; references 16, 18, 23-29) . Only five
Qregion genes have been indentified from a C3H/HeN genomic library (Watts,
S., unpublished data).
1 Sequences were aligned only in exons 2, 3, and 4. Exon lengths used were
as follows: exon 2, 270 bases; exon 3, 276 bases ; exon 4, 276 bases.
I). In particular, we have compared the DNA sequences of the 1591 class I genes
to those of three Tla region genes from different serologically defined haplotypes:
Tlaa (23), Tlab (24), and Tla` (25). At least 146 differences are observed between
the 1591 and Tla genes within the exon 2 and 3 sequences compared. Furthermore,
no Tla-containing cloneisolated from genomicC3H libraries appears to be homolo-
gous to any of the novel tumor genes at the level of restriction mapping (Watts, S.,
unpublished data). Given the sum of these data, it is difficult to conclude that the
three 1591-derived classI geneswere generatedby any limited mutational or recom-
binational mechanism from the class I genes of C3H/HeN.
Identification of Potential Phylogenetic Origins of the Novel 1591 Class I Genes.
￿
Since
no likely progenitor loci for the 1591 genes have been found within the C3H MHC,
it is important to consider whether any alternative phylogenetic origins might be
discerned. One possible indication ofan allogeneic origin for the novel MHC prod-
ucts of 1591 couldbe inferred from thepattern of serological crossreactivityexhibited
by the tumor (see Table II). In particular, the C3H anti-1591 mAb, CP3F4, recog-
nizes not only the A166 antigen but also H-2K' and a product expressed by the H-2q
haplotype, while CP28 reacts with A216, H-2Dd, and an H-25 product, probably
H-K5. Although the sequences of A166 and A216 indicate that these molecules are
clearly distinct from H-2Kd and H-2D', these novel antigens might, in principle,
be related to H-2q and H-25 haplotype products. This possibility is supported by
A149
Exon 21
A166 A216 A149
Exon 3
A166 A216
Exon
A149
4
A216
H-2Kk 20 27 26 23 27 20 12 4
H-2Dk 26 23 31 21 22 21 4 10
Kl k 38 34 42 53 53 58 10 15
Qlk 29 30 38 54 53 60 6 13
Q2k 17 19 34 38 38 42 9 16
Q4k 28 26 33 30 31 36 13 17
Q5k 52 55 56 46 45 35 17 28
Q10k 33 34 44 26 29 52 11 17
TIaa 88 87 88 71 69 71 24 29
TIab 80 79 80 69 67 70 22 28
TIa` 81 80 81 68 66 69 23 29
H-2Kb 27 30 17 28 31 19 9 2
H-2Db 11 15 31 14 12 25 0 8
H-2Kd 36 31 28 17 17 22 11 14
H-2Dd 33 31 11 22 22 24 7 7
H-2Ld 1 5 29 8 10 21 0 9
H-2DP 32 32 22 24 23 22 4 9
A149 - 8 31 - 8 21 - 8
A166 - - 29 - - 20 0 8LINSK ET AL.
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TABLE II
Serological Reactivities of several H-2-speck mAbs by RIA
- H-2KkDgLq.
1 H-2Kq verified by reactivity with 16-1-11 rnAb (30).
the observation that H-2q haplotype cells are also recognized by several mAbs (28-
14-8, 30-5-7, and 34-1-2)that reactwith theA149 and/or A166 antigens. In addition,
C3H anti-1591 CTL populations exhibit strong reactivity with H-2q haplotype cells
(31). Therefore, it is important to determine to what extent structural homology
between H-2q and H-2s products and the 1591 tumor antigens might be responsible
for the observed serological similarities.
In fact, like 1591, B10.AKM cells (Kk , Dq, Lq) appear to express at least two dis-
tinct H-2D region class I products that are highly homologous to H-2Ld (32). Like
A149, H-2Lq (also referred to as H-2Rq) reacts with the mAb 28-14-8. A166 and
H-2Dq are both recognized by the antibodies 28-14-8 and 30-5-7 (33). The limited
peptide sequence analysis that has been performed on these H-2q haplotype prod-
ucts indicates that they are nearly identical to A149 and A166, respectively (32). In
addition, the sequence of a cDNA clone derived from SWR/J liver is 99.4% iden-
ticalto A149 over 1,368 basescompared (Jay, G., personal communication). On the
basis of these observations, we previously proposed that A149 and A166 are func-
tionally equivalent to the H-2D region products of the H-2q haplotype (31). Re-
cently, the class I genes encoding both the H-2Lq and Dq antigens were isolated
from a B10.AKM genomic library (33). The limited DNA sequence derived from
the 5' regions ofthese clones confirms the structural identity noted between the 1591
and H-2q products. However, several point differences are observed between the in-
tronic sequencesof these genes, suggesting that the 1591 genes might not be directly
derived from the B10.AKM H-2Dq and Lq alleles. Nonetheless, given the range of
divergence that might be attributable to DNA sequencing differences, point muta-
tion events in thecourse oftumorgrowth or molecularcloning, or subtle allelic vari-
ation between B10.AKM and other H-2q-related haplotypes, the level of homology
observed is striking. Therefore, the sum ofthese data indicates that the 1591 tumor
Antigens Cell line CP28 CP3F4
Monoclonal antibody
30-5-7 28-14-8 34-1-2 34-4-20
cpm
A149 H12-23 .1 831 114 646 28,169 3,420 126
A166 H12-9 .2 220 8,114 34,633 19,082 16,139 131
A216 H12-20.1 28,613 143 121 155 22,573 137
1591 1591 28+ 5,985 3,484 9,571 13,775 9,411 115
H-2Kd H40-5 111 3,336 127 102 17,902 97
H-2Dd K8-30P 9,208 129 68 83 12,085 12,329
H-2Ld K2a-7 171 139 18,852 18,723 1,206 14,133
H-2" B10.AKM LF 339 8,299 13,879 13,744 10,431 396
H-2q1 Swiss 3T3 298 18,753 27,383 27,568 26,103 7,061
H-2k Ltk- 148 103 95 84 65 98
H-26 BL-5 148 147 110 9,598 1,857 194
H-2' RIIIS/J LF 90 100 97 94 7,601 12,707
H-23 A. SW LF 12,646 219 103 87 13,991 1281048
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bears two H-2-like antigens that exhibitextensive structural and functional homology
to the H-2D and H-2L products of the H-2q haplotype .
Genomic Southern Blot Analysis of ClassIPolymorphisms in the 1591 Tumor .
￿
Given the
strong structural homology that exists between A149 andA166and the H-2D region
genes of the H-2q haplotype, it was of interest to determine whether additional ho-
mologies exist between 1591 and the H-2q haplotype . Such homologies might be
identified as non-C3H restriction fragments shared between 1591 and H-2q haplo-
type genomic DNA. Fig . 1 shows the results of Southern blot analysis using both
FIGURE 1 .
￿
ASouthern blot ofgenomic
DNA digested with Pst I was hybrid-
ized to a 5' exon 3-specific probe (Aat
II-Xba I from A149) (a) or a coding
region probe corresponding to the 1.1-
kb polymorphic Pst I fragment ofA149
(b) . (a) Reprobing of the filter in b .
C3H/HeNDNAwas derived from the
C31-1-derivedUVinduced tumor, 2240,
which shows no polymorphism when
compared with bona fide C3H/HeN
DNA digested with Pst I . Arrows in-
dicate polymorphic restriction frag-
ments in 1591 relative toC3H that are
reconstituted by cloned tumor genes
(lanes 1-3) andB10.AKMDNA(lane
5) . The dot in a indicates the 2.2-kb
polymorphic restriction fragment re-
constituted with A216 DNA .LINSK ET AL.
￿
1049
5' and 3' class I coding region probes. In these blots Pst I digests ofgenomic DNA
from various MHC haplotypes as well as 1591 and a C3H/HeN control are com-
pared. In addition, polymorphic restriction fragments detected in 1591 are recon-
stituted by the addition of cloned class I genes or B10.AKM DNA to C3H/HeN
DNA. Itis clearfromtheseblots that 1591 bears atleast three 3'andone5'hybridizing
class I fragments that are neither found in C3H/HeN DNA nor accounted for by
the A149, A166, or A216 genes. At lower stringency, seven such 5' fragments can
be discerned (data not shown). Intriguingly, each ofthese novel fragments, as well
as thosecorrespondingtoA149andA166, isalso found in theB10.AKMDNA. How-
ever, it is important to note that B10.AKM does not contain a 2.2-kb restriction
fragment equivalent to that reconstituted with A216 DNA. This result is consistent
with the observation that H-2q haplotype cells do not express an A216-like product,
as measured by their lack ofreactivity with the CP28 mAb (Table II). In contrast,
BALB/cj and SJL/J DNA both appear to bear a 2.2-kb restriction fragment, and
both H-2d and H-23 haplotypes are CP28+ . Comparable results are seen with the
restriction enzymes Barn HI, Pvu II, and Taq I (data not shown). In each ofthese
cases, between one and four non-C3H restriction fragments are found in the 1591
DNA, and in every example these restriction fragments can be reconstitutedby the
addition ofB10.AKM DNA. Furthermore, in no case is a restriction fragment seen
in the B10.AKM digests that is not also found in 1591. Therefore, except for the
restriction fragments corresponding to the A216 gene, the genomic Southern blot
pattern of 1591 resembles that of an admixture ofC3H/HeN and B10.AKM DNA.
A possible origin of the CP28-reactive A216 is discussed below.
Analysis ofNon-MHC Genetic Background in the 1591 Tumor.
￿
Since 1591 appeared
to be heterozygous with respect to the class I genes ofthe MHC, it was ofinterest
todeterminewhetherany heterozygositymight bedetected elsewhereinthegenome.
To this end thepolymorphiclocus RP2, located on the 7th chromosome, was exam-
ined(34). Mostcommon inbred strainsofmice, suchasC3H, C57BL/10, andBALB/c,
carry an allele at this locusthat generates a 1.9-kb Hind III fragment. Several Swiss-
derived strains such as SJL and SWR exhibit a 2.2-kb allele. In Fig. 2 it is readily
apparent that 1591 carries both alleles. Two bands are present in every preparation
of 1591 tested, including the 1591 CP28- antigen loss variant. The band is not
present in the DNA of2240, aC3H/HeN UVfibrosarcoma derived in parallel with
1591.
The genetic constitution ofthe 1591 tumor at the a-glucuronidase locus was also
examined. C3Hisunique amonginbred strains ofmicein having aR-glucuronidase
allele whose product is relatively unstable at elevated temperatures (22). Therefore
the presenceofnon-C3H genetic material wouldlikely be reflectedasenhancedtem-
perature stability ofa-glucuronidase activity over that ofbona fide C3H cells. In
fact as shown in Fig. 3, the relative stability at 70°C of a-glucuronidase activity
found in 1591 whole-cell extracts is intermediate between that ofC314-derived Ltk-
and KB29 fibroblast lines andB10, B10.AKM, or Swiss-derived fibroblast lines. Com-
parable results are found at 65°C (Data not shown). Thus, 1591 appears to be het-
erozygous at the GUS locus as well.
DetectionofClassIAlterations in Distinct UVinduced Tumors.
￿
The data described above
suggest that the novel class I antigens detected on the 1591 tumor might represent
an artifact of genetic heterozygosity, and therefore, might not be directly related1050
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to theUV etiology ofthe tumor. Nonetheless, given theextreme antigenicity ofmany
UV tumors like 1591, it is intriguing to postulate that class I alterations might occa-
sionally be responsible for the expression of antigenic products . To estimate the ex-
tent to which class I alterations might in fact occur in other UV tumors, a panel
of 16 C3H-derived, UV induced tumors has been screened for the presence of class
I polymorphisms . In fact, two of these tumors, LR335 and 2240, each appear to
bear a distinct polymorphic Taq I fragment (Fig . 4) . Using Pst I on the otherhand,
each ofthesetumors appears identical to C3H(datanot shown) . In thecase of LR335,
the novel Taq I fragment appears to be derived from a restriction fragment of a size
contributed by H-2D' . Given the limited extent of class I polymorphism in these
tumors, each ofthese examples could representabona fideMHC mutation or recom-
a
a
0
e
K
Time (minutes) et 7O*C
FIGURE 2 .
￿
Comparison ofRP2 alleles
in C3H/HeN-derived 2240 DNA, four
independent 1591 preparations includ-
ing the 1591 CP28 antigen loss variant,
C3H/Hej, andSJL/JDNA. This prep-
aration of CP28 - DNAlacks all 1591-
associated class I polymorphism (data
not shown).
FIGURE 3 .
￿
The 1591 tumor is heterozygous at
the 0-glucuronidase locus . Aliquots ofcell extracts
were incubated at 70°C for the times shown . Cell
lines examined were C3H Ltk- fibroblasts (")
andKB29 fibrosarcoma(O), Swiss 3T3 (/)and
B10.AKM heart-lung fibroblasts (0), C57BL/10-
derived BL-5 fibroblasts (+), and 1591 fibrosar-
coma (0) . Results are presented as percent ini-
tial /3-glucuronidase activity remaining at each
time point .LINSK ET AL .
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FIGURE 4 .
￿
A Southern blot ofTaq I-di-
gested DNA from several C3H-derived,
UVinduced tumors . Arrows indicate poly-
morphic restriction fragments in 2240 (top)
andLR335 (bottom) .The probe is the same
as in Fig. 1 a .
bination event . However in neitherof these cases is it possible to determine whether
the mutation existed in the genome of the autochthonous host or whether it arose
de novo . Furthermore, itwould be difficult to determine whetherthese class I poly-
morphisms are relevant to the antigenicity of the tumors in the absence ofextensive
additional analysis .
Discussion
Previously we cloned and determined theDNA sequence ofthree H-2-like genes
that encode tumor-specific rejection antigens expressed by the UVinduced,
C3H/HeN-derived fibrosarcoma 1591 . These genes, called A149, A166, and A216,
do not appear to exist intact within the MHC of the parental C3H strain, since
each accounts for a polymorphic restriction fragment in 1591 genomicDNA(15, 16).
In this report we present evidence that sheds light on the potential origin of these
novel genes . First we show that analysis of the DNA sequences of a complete set
ofC3H/HeN H-2 and Qa genes fails to identify a convincing progenitor for any
of the novel tumor genes . In contrast, two of the tumor genes, A149 and A166, ex-
hibit striking structural similarity to the H-2Lq and H-2Dq antigens, respectively.
This structural homology is consistent with a strong functional homology that has
been previously described (31) . Furthermore, the similarity between some of thenovel
class I genes from 1591 and class I genes from the H-2q haplotype appears to ex-
tend beyond those genes that have been sequenced . In fact, H-2q haplotype class
I genes appear to be able to account for all of the class I polymorphism detected
by genomic Southern blot in 1591, except for those bands associated with the A2161052
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gene. Intriguingly, the complete set of class I polymorphisms in 1591 appears to be
linked to asingle chromosome, since all ofthe novel restriction fragments arelacking
from the 1591 CP28- tumor variant, which was selected for the loss of the A216
product alone (13, 15, 17; data not shown). Finally, we demonstrate that genetic het-
erozygosity exists at two loci outside of the MHC of this tumor. We believe that
the most parsimonious mechanism to account for all of these observations is that
the set of polymorphic class I genes in 1591 was originally acquired as a haplotype
from some unidentified allogeneic donor exhibiting homology to H-2q.
Given the homology observed between A149 and A166 and H-2q haplotype an-
tigens, it is of interest to determinewhetherA216 exhibits homology with anyknown
class I antigen. As shown in Table II, the CP28 mAb recognizes not only A216,
but also H-2D' and an unidentified H-2s haplotype product. This antibody does
not recognize H-2q to any significant extent. Intriguingly, a 2.2-kb Pst I fragment,
similarto that accounted forby A216 in the 1591 DNA, can also be detected in SJL/J
DNA. Comparison with the congenic recombinant line B10.S(8R) (Kk, Dg) indi-
cates that this band maps to the K-end of the MHC (Linsk, R., unpublished obser-
vation). Therefore, ofthe class I genesandproducts examined by serology and genomic
Southern blotting, H-2Ks appears most consistent with that determined for A216.
Intriguingly, out of 24 human and mouse class I products examined at the level of
primary structure, only A216 and H-2Dd are structurally consistent with the limited
peptide sequence data available for the H-2K9 antigen (35, 36).
The apparent similarity between A216 and H-2K$ is especially intriguing since
both the H-2q and H-2s haplotypes are found within Swiss mice. Swiss mice are an
outbred population of mice descended from a founder population of nine mice in
1926 (37). In addition, severalinbred strains have been derived from thesefounders,
including SWR/J (H-2q), SJL/J (H-2s), and NFS/N (Ks, Dq) (38). Recent isozyme
analysis of several populationsof Swissmice indicatesthat these populationsremain
a reservoir of geneticvariability (39). Indeed, within these populationscanbe found
individuals that bear each of the isozyme alleles that have been shown to be shared
by 1591 and C3H (13, 39-41). For example, SJL/J and SWR/J each differ from
C3H/Hej at only one of the seven isozymeloci at which 1591 was previously shown
to be identical to C3H. In addition both of these inbred strains exhibit an allele
at the RP2 locus that appears identical to that observed in 1591, while the strain
NFS/N potentially bears an MHC haplotype compatible with that observed in the
tumor (38). Therefore, within the population of Swiss mice, individuals are likely
to existwhose genetic constitutions would be consistent with their servingas donors
of the apparently allogeneic information in 1591. Given the existence of this pool
of genetic information, as well as the homology observed between A149 and A166
and twoD region genesof an established MHC haplotype, it is difficult to conclude
that the novel 1591 class I genes are indeed derived from endogenous C3H genes
in the absence of further positive data.
Ifthe conclusions described above are correct, they suggest that the results of the
original 1591 sequencing studies might prove to be informative about the evolution
of the H-2q haplotype. In particular, the extreme sequence homology (»99%) ob-
served throughout the 3' coding and untranslated regions of the H-2Lq and Dq
genes, i.e., from the 1591 tumor sequences (16), might indicate that these two genes
are derivedby the diversificationof tworecently duplicated classI genes. Gene dupli-LINSK ET AL.
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cation has been previously proposed to account forthe patternof structural homology
observed between pairs of Q;region genes in the C57BL/10 mouse (42). However,
no clear examples of gene duplication have yet been identified within the H-2 re-
gion. The BALB/c mouse contains five H-2D genes, with H-2Dd and three other
loci proximal to H-2Ld. It has been proposed, based on restriction map homology
and crossreactivity of flanking probes with Qa-containing clones, that unequal ho-
mologous recombination between two distinct haplotypes couldhave accounted for
this expanded H-2D region (43). Patterns ofcrossreactivity of these flanking probes
with H-29 genomic DNA indicated that the organization of the H-2D9 region might
be similar to that of BALB/c (43), but without a complete physical map of the q
haplotype the parallels between the BALB/c molecules and the highly homologous
H-2L9 and H-2D9 are unclear.
If H-2L9 and H-2D9 are derived by relatively recent duplication, then they pro-
vide an exampleofhow H-2 genesdiversify, namely, by pointmutation. It has been
proposed that selective pressures might exist on class I molecules for clustered se-
quence changesviagene conversion which could substantially alterthe immunolog-
ical function of a particular restriction element (44-46). Most of the H-2Kbm mu-
tants (47), as well as the recently characterized H-2Kkm2 mutant (48), must have
been generated by gene conversion as they involve multiple amino acid substitu-
tions. A gene conversion model has also been invoked forthe single amino acid sub-
stitutions in H-2Kbm5, H-2Kbm16 (47), and H-2K" (49) since the mutant sequence
is shared by other class I genes in the respective haplotypes, although point muta-
tions cannot be ruled out. It is important to remember that the H-2Kbm mutants
were detected by achange in histocompatibility significant enough to elicit relatively
swift graft rejection. Single point mutations might not result in the expression of
newmolecules sufficiently antigenic to permit detection by standard skin graft rejec-
tion (50). Examination of nonimmunogenically screened closely related classI genes
would be expected to reveal this more basic mechanism of divergence. It is therefore
not surprising that all of the sequence substitutions between the two H-2q-like mol-
ecules from the 1591 tumor seem to have arisen by pointmutation. There areseveral
closelyspaced differences in the polymorphic regionsin exons2 and 3, but no donors
exist for these among the Qa sequences available to date (data not shown). While
gene conversion may play asignificant role in the evolution of this multigene family,
the impact of point mutation cannot be underestimated.
The results presented here do not imply that genetic contamination is generally
responsible for the phenomenon of UV tumorantigenicity. On thecontrary, a large
number of experiments over several years in several labs have consistently demon-
strated that UVinduced tumors are highly antigenic and are rejected by im-
munocompetent syngeneic hosts (4, 7, 51, 52). Similarly, the results here do not ne-
gate thevalueor relevance ofpast studies that have examined the interaction between
the immune system of UV-irradiated hosts and tumor transplants. These studies
have demonstrated that many UV-induced tumors, including 1591, are specifically
tolerated by UV-irradiated hosts, and that this tolerance appears to be mediated
by specific suppression (8, 51, 53-58).
Unfortunately, it is not yet possible to resolve theorigin ofthe diverse antigenicity
associated with UV tumors. Most likely, these antigens reflect the random muta-
genic effects of UV radiation. Recent insights into the mechanism of antigen pre-1054
￿
ORIGIN OF 1591 TUMOR ANTIGENS
sentation suggest that any mutant cellular peptide can become antigenic if it can
bind to self-MHC restriction elements (59) . The mutant gene encoding such an an-
tigenic product has recently been isolated from an antigenic variant of the P815
mastocytoma (60). In addition, tumor-specific antigens have recently been biochem-
ically isolated from several chemically induced tumors (6, 61-64). In none of these
cases have the antigenic products proven to be mutated class I molecules.
In fact, it remains possible that class I mutation might be one mechanism by which
tumor antigenicity arises. The genomic Southern blots shown in Fig. 4 show that
polymorphisms can be found in some UVinduced tumors. However, in no cases
except 1591 have mutated class I genes been directly implicated in the antigenicity
of a UV or chemically induced tumor. If a tumor-specific class I mutant were in
fact to be defined in such an antigenic tumor, the question of its significance would
remain unresolved. As we have recently discussed, the relevance ofclass I alterations
associated with tumor progression remains controversial. It is unclear that the ex-
pression of a novel MHC antigen by a tumorwould have any functional significance
beyond that associated with the expression of any strong antigen (65).
Summary
Previously, we cloned and sequenced the threenovel MHC class I genes expressed
by the C3H UV fibrosarcoma, 1591. We have extended the analysis ofthe polymorphic
nature of these genes relative to the C3H strain. Scattered nucleotide differences
among the tumor genes as compared with the C3H H-2 and Qa sequences make
it highly unlikely that the novel tumor genes were generated by recombination be-
tween endogenous C3H sequences. Given that two of the tumor clones, A149 and
A166, are remarkably similar in amino acid and DNA sequence to H-2Lq and
H-2Dq, respectively, we also examined the 1591 RP2 and GUS loci for evidence
of polymorphism. Compared with C3H and B10.AKM, 1591 appears to be hetero-
zygous at each of these loci, consistent with an H-2q origin for the two novel 1591
class I genes. Interestingly, the third tumor gene, designated A216, shares certain
characteristics with the H-2K5 antigen, reminiscent of the naturally occurring com-
bination of H-2K1, H-2Dq, and H-2Lq antigens found in some Swiss mouse strains.
As a result, we propose that the non-C3H/HeN characteristics displayed by the 1591
tumor point to a non-C3H origin for the novel tumor class I genes of 1591.
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Gordon Watson who gave us the RP2 probe. Finally, we are very grateful to Gilbert Jay,
Mike Fisher, and Minnie McMillan for valuable discussions.
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